0000000000660447

AUTHOR

P. Pommier

showing 2 related works from this author

OC-0284: First results of the French cohort ANABASE : treatment and outcome in non-metastatic anal cancer

2018

IF 4.942 (2017); International audience

Oncologymedicine.medical_specialtybusiness.industry[SDV.CAN]Life Sciences [q-bio]/Cancer02 engineering and technologyHematology021001 nanoscience & nanotechnologymedicine.diseaseOutcome (game theory)3. Good health[SDV.CAN] Life Sciences [q-bio]/CancerOncology[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieInternal medicineCohort0202 electrical engineering electronic engineering information engineeringmedicineNon metastaticAnal cancer020201 artificial intelligence & image processingRadiology Nuclear Medicine and imaging[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie0210 nano-technologybusiness
researchProduct

What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort

2021

International audience; Introduction: for localized T1N0 squamous cell carcinoma of the anus (SCCA) standard radiotherapy (RT) may result in overtreatment and alternative strategies are debated. Methods: T1N0M0 SCCA treated between 2015 and 2020 by local excision (LE) or RT were analyzed from the French prospective FFCD ANABASE cohort. Treatment strategies, recurrence-free and colostomy-free survivals (RFS, CFS) and prognostic factors were reported. Results: among 1135 SCCA patients, 99 T1N0M0 were treated by LE(n = 17,17.2%), or RT ( n = 82,82.8%) including RT alone ( n = 65,79.2%) or chemo-RT ( n = 17, 20.7%). Median follow-up was 27.2 months [0.03 and ndash;54.44]. Median tumor size were…

Malemedicine.medical_specialtyLocal excisionLocal excisionmedicine.medical_treatmentAnal Canal[SDV.CAN]Life Sciences [q-bio]/CancerGastroenterologyDisease-Free Survival03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineAgedRetrospective StudiesAged 80 and overUnivariate analysisHepatologyRadiotherapybusiness.industryOptimal treatmentGastroenterologyAnal Squamous Cell CarcinomaChemoradiotherapyMiddle AgedAnusAnus Neoplasms3. Good healthRadiation therapymedicine.anatomical_structureAnal canal carcinoma030220 oncology & carcinogenesisCohortCarcinoma Squamous CellFemaleFrancebusinessChemoradiotherapy
researchProduct